Menin and Memory Loss: What Do D-Serine Studies Show?

✓ Medically reviewed | Published: | Evidence level: 1A
Renewed coverage of a 2023 mouse study highlights how the brain protein Menin and the amino acid D-serine may influence age-related memory changes. The findings identify a research target, but they do not establish a treatment for human dementia. [ScienceDaily coverage](https://www.sciencedaily.com/releases/2026/10/261009025708.htm)
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Research

Quick Facts

Menin Assessment
30 days after treatment
Mouse D-Serine Course
3 weeks
Separate Human Trial
50 healthy older adults

How could Menin influence brain aging and memory?

Quick answer: Mouse experiments suggest Menin helps regulate inflammation and production of a molecule involved in memory signaling.

The research, published in PLOS Biology in March 2023, examined Menin in the hypothalamus, a brain region involved in metabolic regulation. Reducing Menin in selected neurons accelerated several age-associated changes. Restoring it through experimental gene delivery in older mice improved learning and memory performance, alongside measures including bone mass and skin thickness assessed after 30 days. [Original Menin study](https://doi.org/10.1371/journal.pbio.3002033)

The researchers also connected Menin to D-serine production. Giving mice D-serine in drinking water for three weeks improved cognitive test performance. These were distinct interventions: supplementing an amino acid did not demonstrate all the effects of restoring Menin. The experiments support a biological connection worth investigating, while leaving its relevance to human treatment unresolved. [Study methods and findings](https://doi.org/10.1371/journal.pbio.3002033)

Has D-serine improved memory in human studies?

Quick answer: One small trial found improvement on a spatial learning task, but it did not establish lasting benefits or dementia prevention.

D-serine helps activate NMDA receptors, which participate in learning and memory. A randomized, double-blind crossover trial published in Oncotarget in 2016 tested a single dose against placebo in 50 healthy older adults. Participants completed both treatment conditions on separate visits. Performance improved on the Groton Maze Learning Test, which assesses spatial learning and problem-solving, but other cognitive measures and mood did not significantly improve. [Human D-serine trial](https://pubmed.ncbi.nlm.nih.gov/26933803/)

The distinction between an immediate test result and protection against dementia is substantial. This experiment did not determine whether repeated treatment preserves independence, slows disease progression, or remains safe over prolonged use. Its participants were healthy older adults, so the results also cannot establish effectiveness in people with Alzheimer's disease. The appropriate interpretation is a preliminary signal that needs confirmation through longer clinical trials. [Trial design and limitations](https://pmc.ncbi.nlm.nih.gov/articles/PMC4914255/)

What should people concerned about memory loss do now?

Quick answer: Seek assessment for persistent memory changes and prioritize established health measures rather than treating these findings as a supplement recommendation.

The National Institute on Aging does not recommend any vitamin or supplement for preventing Alzheimer's disease or other cognitive decline. Its guidance emphasizes managing health conditions, staying physically active, maintaining social connections, and reviewing medicines that may affect thinking. These measures support overall health, although none guarantees dementia prevention. [NIA cognitive health guidance](https://www.nia.nih.gov/health/brain-health/cognitive-health-and-older-adults)

Memory concerns also deserve attention beyond the search for a new treatment. Depression, medication effects, and other health problems can affect cognition. A clinical review can help identify contributing factors and determine whether further assessment is needed. Bring a list of medicines and supplements to the appointment, and discuss concerns before changing prescribed treatment. [NIA advice on health conditions and medicines](https://www.nia.nih.gov/health/brain-health/cognitive-health-and-older-adults)

Frequently Asked Questions

No. The original paper appeared in March 2023; ScienceDaily revisited it in October 2026. Recent coverage should not be mistaken for a newly completed experiment. [Original publication](https://doi.org/10.1371/journal.pbio.3002033)

No. It assessed short-term cognitive performance in healthy older adults and did not measure Alzheimer's prevention or long-term disease outcomes. [Human trial](https://pubmed.ncbi.nlm.nih.gov/26933803/)

Discuss persistent memory concerns with a healthcare professional first. Supplements are not recommended for preventing cognitive decline, and reviewing health conditions and medicines may identify relevant contributors. [NIA guidance](https://www.nia.nih.gov/health/brain-health/cognitive-health-and-older-adults)

References

  1. Leng L, Yuan Z, Su X, et al. Hypothalamic Menin regulates systemic aging and cognitive decline. PLOS Biology. 2023;21(3):e3002033. [Study](https://doi.org/10.1371/journal.pbio.3002033)
  2. Avellar M, Scoriels L, Madeira C, et al. The effect of D-serine administration on cognition and mood in older adults. Oncotarget. 2016;7(11):11881-11888. [Study](https://doi.org/10.18632/oncotarget.7691)
  3. National Institute on Aging. Cognitive Health and Older Adults. [Guidance](https://www.nia.nih.gov/health/brain-health/cognitive-health-and-older-adults)
  4. ScienceDaily. Scientists find hidden driver of aging and a simple amino acid that fights memory loss in mice. October 12, 2026. [News report](https://www.sciencedaily.com/releases/2026/10/261009025708.htm)